根据最终合并协议,Viewpoint的每一股已发行和流通股份将转换为获得Isoray 3.3212股的权利。Viewpoint股东将拥有Isoray完全稀释的流通股49%的股份。
$华海药业(SH600521)$ $华东医药(SZ000963...查看全文
$IsoRay, Inc.(ISR)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-11-09 AccNo: 0001437749-18-020265 Size: 481 KB 网页链接
$IsoRay, Inc.(ISR)$ DEF 14A - Other definitive proxy statements Filed: 2018-11-09 AccNo: 0001437749-18-020263 Size: 1 MB 网页链接
$IsoRay, Inc.(ISR)$ 8-K - Current report Filed: 2018-11-08 AccNo: 0001437749-18-020073 Size: 158 KBItem 2.02: Results of Operations and Financial ConditionItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$IsoRay, Inc.(ISR)$ 8-K - Current report Filed: 2018-11-08 AccNo: 0001437749-18-019895 Size: 30 KBItem 1.01: Entry into a Material Definitive AgreementItem 1.02: Termination of a Material Definitive AgreementItem 3.03: Material Modifications to Rights of Security HoldersItem ...
$IsoRay, Inc.(ISR)$ PRE 14A - Other preliminary proxy statements Filed: 2018-10-30 AccNo: 0001437749-18-019066 Size: 871 KB 网页链接
$IsoRay, Inc.(ISR)$ 美东时间 2018-11-08 盘后 披露财报,预期EPS -0.02 网页链接
$IsoRay, Inc.(ISR)$ S-1 - General form for registration of securities under the Securities Act of 1933 Filed: 2018-10-19 AccNo: 0001437749-18-018510 Size: 262 KB 网页链接
$IsoRay, Inc.(ISR)$ 8-K - Current report Filed: 2018-10-12 AccNo: 0001437749-18-018239 Size: 90 KBItem 1.01: Entry into a Material Definitive AgreementItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory A...
$IsoRay, Inc.(ISR)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-09-26 AccNo: 0001437749-18-017492 Size: 7 MB 网页链接
$IsoRay, Inc.(ISR)$ 8-K - Current report Filed: 2018-09-25 AccNo: 0001437749-18-017429 Size: 271 KBItem 1.01: Entry into a Material Definitive AgreementItem 1.02: Termination of a Material Definitive AgreementItem 2.02: Results of Operations and Financial ConditionItem 8.01: ...